Cost Analyses Of Adjunct Colony Stimulating Factors For Older Patients With Acute Myeloid Leukaemia: Can they Improve Clinical Decision Making?

Author： Bennett C.L.   Schumock G.T.  

Publisher： Adis International

ISSN： 1170-229X

Source： Drugs & Aging, Vol.20, Iss.7, 2003-01, pp. : 479-483

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Colony-Stimulating Factors in the Treatment of Older Patients with Acute Myelogenous Leukaemia

By Bolam S.   Hamblin T.  

Drugs & Aging, Vol. 15, Iss. 6, 1999-12 ,pp. : 451-460

Adis International

Access to resources Recommend Favorite

CER: what factors guide healthcare decision making?

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 605, 2010-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Granulocyte colony-stimulating factors: Acute myeloid leukaemia?: case report

By  

Reactions Weekly, Vol. 1, Iss. 1223, 2008-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Is There a Role for Pharmacoeconomics in Decision Making?

By van Luijn Johan C.F.  

PharmacoEconomics, Vol. 30, Iss. 10, 2012-10 ,pp. : 979-979

Adis International

Access to resources Recommend Favorite

Granulocyte colony-stimulating factor (G-CSF) does not appear to have any additional benefit in patients with acute myeloid leukaemia (AML) receiving chemotherapy

By  

Inpharma, Vol. 1, Iss. 1439, 2004-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite